Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Gallbladder and Bile Duct Disorders, and Cardiac electrophysiology and arrhythmias.
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
Liver transplant‐free survival according to alkaline phosphatase and <scp>GLOBE</scp> score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis
Milder disease stage in patients with primary biliary cholangitis over a 44‐year period: A changing natural history
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study